$PRPO
Precipio, Inc.

2024 Q1 Form 10-K Financial Statement

#000155837024004365 Filed on March 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $3.432M $4.329M $15.20M
YoY Change 21.83% 81.05% 61.46%
Cost Of Revenue $2.512M $2.316M $9.179M
YoY Change 21.47% 29.17% 32.99%
Gross Profit $920.0K $2.013M $6.018M
YoY Change 22.83% 236.62% 139.76%
Gross Profit Margin 26.81% 46.5% 39.6%
Selling, General & Admin $100.0K
YoY Change 0.0%
% of Gross Profit 1.66%
Research & Development $1.700M
YoY Change 0.0%
% of Gross Profit 28.25%
Depreciation & Amortization $304.0K $318.0K $1.308M
YoY Change -1.94% -1.85% 7.3%
% of Gross Profit 33.04% 15.8% 21.73%
Operating Expenses $2.994M $2.867M $13.64M
YoY Change -20.69% -1.95% -10.9%
Operating Profit -$2.074M -$854.0K -$7.620M
YoY Change -31.46% -63.28% -40.45%
Interest Expense -$5.000K -$6.000K -$18.00K
YoY Change 25.0% -127.27% -103.03%
% of Operating Profit
Other Income/Expense, Net $65.00K $65.00K
YoY Change
Pretax Income -$2.079M $925.0K -$5.853M
YoY Change -31.39% -140.52% -51.94%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$2.079M $925.0K -$5.853M
YoY Change -31.39% -140.39% -52.02%
Net Earnings / Revenue -60.58% 21.37% -38.51%
Basic Earnings Per Share -$1.46 -$4.51
Diluted Earnings Per Share -$1.46 $0.65 -$4.51
COMMON SHARES
Basic Shares Outstanding 1.430M 1.420M 1.298M
Diluted Shares Outstanding 1.426M 1.298M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $776.0K $1.502M $1.502M
YoY Change -63.76% -56.4% -56.4%
Cash & Equivalents $776.0K $1.502M $1.502M
Short-Term Investments
Other Short-Term Assets $381.0K $495.0K $495.0K
YoY Change -15.33% -1.0% -4.99%
Inventory $532.0K $384.0K $384.0K
Prepaid Expenses
Receivables $906.0K $1.301M $1.301M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.595M $3.682M $3.682M
YoY Change -35.04% -35.52% -35.52%
LONG-TERM ASSETS
Property, Plant & Equipment $672.0K $1.525M $1.525M
YoY Change -19.42% 73.89% -19.61%
Goodwill
YoY Change
Intangibles $12.58M $12.82M
YoY Change -7.01% -6.9%
Long-Term Investments
YoY Change
Other Assets $64.00K $76.00K $76.00K
YoY Change -44.83% -41.09% -41.09%
Total Long-Term Assets $14.03M $14.42M $14.42M
YoY Change -9.07% -8.71% -8.71%
TOTAL ASSETS
Total Short-Term Assets $2.595M $3.682M $3.682M
Total Long-Term Assets $14.03M $14.42M $14.42M
Total Assets $16.62M $18.10M $18.10M
YoY Change -14.41% -15.82% -15.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $905.0K $622.0K $622.0K
YoY Change -58.68% -69.54% -69.54%
Accrued Expenses $1.819M $2.042M $2.042M
YoY Change 7.95% 28.91% 14.53%
Deferred Revenue $200.0K $100.0K
YoY Change 100.0% 0.0%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $133.0K $367.0K $367.0K
YoY Change -6.34% 43.92% -11.99%
Total Short-Term Liabilities $3.327M $3.141M $3.141M
YoY Change -26.08% -27.98% -27.98%
LONG-TERM LIABILITIES
Long-Term Debt $99.00K $124.0K $124.0K
YoY Change -22.05% -7.46% -38.61%
Other Long-Term Liabilities $353.0K $407.0K $407.0K
YoY Change -32.12% -29.09% -29.09%
Total Long-Term Liabilities $99.00K $531.0K $531.0K
YoY Change -22.05% 296.27% -31.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.327M $3.141M $3.141M
Total Long-Term Liabilities $99.00K $531.0K $531.0K
Total Liabilities $3.850M $3.672M $3.672M
YoY Change -25.93% -28.52% -29.41%
SHAREHOLDERS EQUITY
Retained Earnings -$100.2M -$98.20M
YoY Change 5.14% 6.39%
Common Stock $14.00K $14.00K
YoY Change -93.99% -93.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.77M $14.43M $14.43M
YoY Change
Total Liabilities & Shareholders Equity $16.62M $18.10M $18.10M
YoY Change -14.41% -15.82% -15.82%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$2.079M $925.0K -$5.853M
YoY Change -31.39% -140.39% -52.02%
Depreciation, Depletion And Amortization $304.0K $318.0K $1.308M
YoY Change -1.94% -1.85% 7.3%
Cash From Operating Activities -$700.0K $111.0K -$3.559M
YoY Change -56.25% -107.4% -53.78%
INVESTING ACTIVITIES
Capital Expenditures $46.00K $126.0K
YoY Change -11.54% -54.51%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 -$46.00K -$126.0K
YoY Change -100.0% -11.54% -54.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.245M
YoY Change 1640.31%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -59.00K -128.0K 1.742M
YoY Change -120.14% -12.93% -874.22%
NET CHANGE
Cash From Operating Activities -700.0K 111.0K -3.559M
Cash From Investing Activities 0.000 -46.00K -126.0K
Cash From Financing Activities -59.00K -128.0K 1.742M
Net Change In Cash -726.0K -63.00K -1.943M
YoY Change -44.33% -96.29% -76.37%
FREE CASH FLOW
Cash From Operating Activities -$700.0K $111.0K -$3.559M
Capital Expenditures $46.00K $126.0K
Free Cash Flow $65.00K -$3.685M
YoY Change -104.19% -53.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.51
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-10.73
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1297851
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1137573
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
47
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
47
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1141013
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1420125
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001043961
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1000000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1000000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1000000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
739000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
877000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
174000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
257000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
612000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1000000
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2023Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-36439
CY2023 dei Entity Registrant Name
EntityRegistrantName
PRECIPIO, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1789357
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
4 Science Park
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
New Haven
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06511
CY2023 dei City Area Code
CityAreaCode
203
CY2023 dei Local Phone Number
LocalPhoneNumber
787-7888
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2023 dei Trading Symbol
TradingSymbol
PRPO
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
10400000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1430292
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023 dei Auditor Name
AuditorName
Marcum LLP
CY2023 dei Auditor Location
AuditorLocation
New Haven, CT
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1502000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3445000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2572000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2354000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1301000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1036000
CY2023Q4 us-gaap Inventory Net
InventoryNet
384000
CY2022Q4 us-gaap Inventory Net
InventoryNet
708000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
495000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
521000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3682000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5710000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
763000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12818000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13768000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
129000
CY2023Q4 us-gaap Assets
Assets
18101000
CY2022Q4 us-gaap Assets
Assets
21504000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
235000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
255000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
132000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
162000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
218000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
199000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
622000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2042000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1824000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1584000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
110000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
119000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3141000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4361000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
106000
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
134000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
18000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
68000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
407000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
574000
CY2023Q4 us-gaap Liabilities
Liabilities
3672000
CY2022Q4 us-gaap Liabilities
Liabilities
5137000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
47
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
47
CY2023Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
38000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1420125
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1141013
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
14000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
11000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
112565000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
108588000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98150000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-92297000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
14429000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16302000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
65000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14429000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
16367000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18101000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21504000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15415000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9820000
CY2023 prpo Allowance For Doubtful Accounts Revenue
AllowanceForDoubtfulAccountsRevenue
218000
CY2022 prpo Allowance For Doubtful Accounts Revenue
AllowanceForDoubtfulAccountsRevenue
408000
CY2023 us-gaap Revenues
Revenues
15197000
CY2022 us-gaap Revenues
Revenues
9412000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9179000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6902000
CY2023 us-gaap Gross Profit
GrossProfit
6018000
CY2022 us-gaap Gross Profit
GrossProfit
2510000
CY2023 us-gaap Operating Expenses
OperatingExpenses
13638000
CY2022 us-gaap Operating Expenses
OperatingExpenses
15307000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-7620000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-12797000
CY2023 prpo Interest Income And Expense Net
InterestIncomeAndExpenseNet
-18000
CY2022 prpo Interest Income And Expense Net
InterestIncomeAndExpenseNet
-12000
CY2022 prpo Gain Loss On Stock Warrants Revaluation
GainLossOnStockWarrantsRevaluation
606000
CY2022 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
25000
CY2023 prpo Gain Loss On Writeoff Of Liability
GainLossOnWriteoffOfLiability
1720000
CY2023 us-gaap Other Income
OtherIncome
65000
CY2023 prpo Other Income Expense
OtherIncomeExpense
1767000
CY2022 prpo Other Income Expense
OtherIncomeExpense
619000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5853000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12178000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023 us-gaap Profit Loss
ProfitLoss
-5853000
CY2022 us-gaap Profit Loss
ProfitLoss
-12178000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
25000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5853000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12203000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.51
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-10.73
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1297851
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1137573
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24604000
CY2022 us-gaap Profit Loss
ProfitLoss
-12178000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
129000
CY2022 prpo Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
11000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3801000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
16367000
CY2023 us-gaap Profit Loss
ProfitLoss
-5853000
CY2023 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
65000
CY2023 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
1760000
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
485000
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
177000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14429000
CY2023 us-gaap Profit Loss
ProfitLoss
-5853000
CY2022 us-gaap Profit Loss
ProfitLoss
-12178000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1225000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1219000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
209000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
187000
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
83000
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
114000
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3000
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4000
CY2022 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
25000
CY2023 prpo Gain Loss On Dissolution Of Joint Venture
GainLossOnDissolutionOfJointVenture
65000
CY2023 prpo Gain Loss On Writeoff Of Liability
GainLossOnWriteoffOfLiability
1720000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1558000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3801000
CY2023 us-gaap Professional Fees
ProfessionalFees
177000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
218000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
406000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-606000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
483000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
745000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-324000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
144000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-451000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-491000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-169000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
165000
CY2023 prpo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-206000
CY2022 prpo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-182000
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-9000
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
101000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
698000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-329000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3559000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7721000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
126000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
277000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-126000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-277000
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
80000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
151000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2245000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
129000
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11000
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
423000
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
214000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1742000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-225000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1943000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8223000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3445000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11668000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1502000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3445000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
42000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
45000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
11000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
34000
CY2023 prpo Prepaid Insurance Financed With Loan
PrepaidInsuranceFinancedWithLoan
372000
CY2022 prpo Prepaid Insurance Financed With Loan
PrepaidInsuranceFinancedWithLoan
413000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
58000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
92000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
12000
CY2023 prpo Variable Interest Entity Dissolution Gain Loss
VariableInterestEntityDissolutionGainLoss
100000
CY2023Q4 prpo Accumulated Net Income Loss
AccumulatedNetIncomeLoss
-5800000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3600000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-98200000
CY2023Q4 prpo Working Capital Deficiency
WorkingCapitalDeficiency
500000
CY2023 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On September 21, 2023 we filed a Certificate of Amendment to our Third Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware, pursuant to which we effected a 1-for-20 reverse stock split (the “Reverse Stock Split”) of our issued and outstanding common stock. The Reverse Stock Split became effective as of 5:00 p.m. (Eastern Time) on September 21, 2023, and our common stock began trading on a split-adjusted basis on the Nasdaq Capital Market at the market open on September 22, 2023. Unless otherwise indicated, all share amounts, per share data, share prices, exercise prices and conversion rates set forth in these notes and the accompanying consolidated financial statements have, where applicable, been adjusted retroactively to reflect this reverse stock split
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Use of Estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. The most significant estimates and assumptions with regard to these consolidated financial statements relate to the allowance for credit losses, assumptions used within the fair value of debt and equity transactions and contractual allowances. These assumptions require considerable judgment by management. Actual results could differ from the estimates and assumptions used in preparing these consolidated financial statements.</p>
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
500000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
300000
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
200000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
500000
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
300000
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
200000
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Concentrations of Risk.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">From time to time, we may maintain a cash position with financial institutions in amounts that exceed Federal Deposit Insurance Corporation insured limits of up to $250,000 per depositor per financial institution. We have not experienced any losses on such accounts as of December 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Service companies in the health care industry typically grant credit without collateral to patients. The majority of these patients are insured under third-party insurance agreements. The services provided by the Company are routinely billed utilizing the Current Procedural Terminology (CPT) code set designed to communicate uniform information about medical services and procedures among physicians, coders, patients, accreditation organizations, and payers for administrative, financial, and analytical purposes. CPT codes are currently identified by the Centers for Medicare and Medicaid Services and third-party payers. The Company utilizes CPT codes for Pathology and Laboratory Services contained within codes 80000-89398.</p>
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
764000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
983000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
754000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
491000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
287000
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022 prpo Amortization Of Debt Issuance Costs Incurred During Partial Noncash Transaction
AmortizationOfDebtIssuanceCostsIncurredDuringPartialNoncashTransaction
100000
CY2023 prpo Amortization Of Debt Issuance Costs Incurred During Partial Noncash Transaction
AmortizationOfDebtIssuanceCostsIncurredDuringPartialNoncashTransaction
100000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2022 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2023 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2023 prpo Presentation Of Insurance Claims And Related Insurance Recoveries
PresentationOfInsuranceClaimsAndRelatedInsuranceRecoveries
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Presentation of Insurance Claims and Related Insurance Recoveries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company accounts for its insurance claims and related insurance recoveries at their gross values as standards for health care entities do not allow the Company to net insurance recoveries against the related claim liabilities. There were no insurance claims or insurance recoveries recorded during the years ended December 31, 2023 and 2022.</p>
CY2022 prpo Insurance Claims Recoveries
InsuranceClaimsRecoveries
0
CY2023 prpo Insurance Claims Recoveries
InsuranceClaimsRecoveries
0
CY2022 us-gaap Advertising Expense
AdvertisingExpense
100000
CY2023 us-gaap Advertising Expense
AdvertisingExpense
100000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1700000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1700000
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
698154
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
224398
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
698154
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
224398
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
91000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
19000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
19000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2116000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1979000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1377000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1102000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
739000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
877000
CY2023 us-gaap Depreciation
Depreciation
300000
CY2022 us-gaap Depreciation
Depreciation
300000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000.0
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000.0
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1000000.0
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
341000
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
389000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
235000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
255000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
106000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
134000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
238000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
32000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
33000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
34000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
16000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
353000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1824000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1584000
CY2023 prpo Reduction In Certain Accrued Expense And Accounts Payable
ReductionInCertainAccruedExpenseAndAccountsPayable
0
CY2022 prpo Reduction In Certain Accrued Expense And Accounts Payable
ReductionInCertainAccruedExpenseAndAccountsPayable
100000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
100000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
612000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
763000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
174000
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
257000
CY2023Q4 prpo Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
786000
CY2022Q4 prpo Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
1020000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
218000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
199000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
132000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
162000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
407000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
574000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
18000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
68000
CY2023Q4 prpo Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
775000
CY2022Q4 prpo Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
1003000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
258000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
80000
CY2023Q4 prpo Lessee Operating And Finance Lease Liability Payments Due Next Twelve Months
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueNextTwelveMonths
338000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
224000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
65000
CY2023Q4 prpo Lessee Operating And Finance Lease Liability Payments Due Year Two
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearTwo
289000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
214000
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
26000
CY2023Q4 prpo Lessee Operating And Finance Lease Liability Payments Due Year Three
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueYearThree
240000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
696000
CY2023Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
171000
CY2023Q4 prpo Lessee Operating And Finance Lease Liability Payments Due
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue
867000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
71000
CY2023Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
21000
CY2023Q4 prpo Lessee Operating And Finance Lease Liability Undiscounted Excess Amount
LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
92000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
625000
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
150000
CY2023Q4 prpo Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
775000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
218000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
132000
CY2023Q4 prpo Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
350000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
407000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
18000
CY2023Q4 prpo Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
425000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M12D
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0800
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0800
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.1063
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.1031
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
200000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
200000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
100000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
100000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
300000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
300000
CY2022 prpo Deemed Dividend
DeemedDividend
0
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
19900000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
18600000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1400000
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3400000
CY2023Q4 prpo Deferred Tax Assets Operating Loss And Tax Credit Carryforwards
DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards
18792000
CY2022Q4 prpo Deferred Tax Assets Operating Loss And Tax Credit Carryforwards
DeferredTaxAssetsOperatingLossAndTaxCreditCarryforwards
18410000
CY2023Q4 prpo Deferred Tax Assets Allowance For Doubtful Debts
DeferredTaxAssetsAllowanceForDoubtfulDebts
616000
CY2022Q4 prpo Deferred Tax Assets Allowance For Doubtful Debts
DeferredTaxAssetsAllowanceForDoubtfulDebts
371000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2182000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1906000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
235000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
140000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21825000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20827000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
201000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
274000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1690000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1950000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
35000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1891000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2259000
CY2023Q4 prpo Deferred Tax Assets Net Of Deferred Tax Liabilities
DeferredTaxAssetsNetOfDeferredTaxLiabilities
19934000
CY2022Q4 prpo Deferred Tax Assets Net Of Deferred Tax Liabilities
DeferredTaxAssetsNetOfDeferredTaxLiabilities
18568000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19934000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18568000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2023 prpo Deemed Dividend
DeemedDividend
0
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1229000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2563000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-173000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-747000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
39000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
51000
CY2022 prpo Effective Income Tax Rate Reconciliation Nondeductible Expense Warrant Liability Revaluation
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantLiabilityRevaluation
-153000
CY2023 prpo Effective Income Tax Rate Reconciliation Meals And Entertainment
EffectiveIncomeTaxRateReconciliationMealsAndEntertainment
21000
CY2022 prpo Effective Income Tax Rate Reconciliation Meals And Entertainment
EffectiveIncomeTaxRateReconciliationMealsAndEntertainment
32000
CY2023 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
72000
CY2023 prpo Effective Income Tax Rate Reconciliation Other Items
EffectiveIncomeTaxRateReconciliationOtherItems
48000
CY2022 prpo Income Tax Reconciliation Income Taxed To Owners On Non Controlling Interest
IncomeTaxReconciliationIncomeTaxedToOwnersOnNonControllingInterest
3000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1366000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3383000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
459535
CY2023 prpo Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
19365
CY2022 prpo Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
5798
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1600000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3800000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
100000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
100000
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
29509000
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
20290000
CY2023 prpo Contractual Allowance And Adjustments
ContractualAllowanceAndAdjustments
14094000
CY2022 prpo Contractual Allowance And Adjustments
ContractualAllowanceAndAdjustments
10470000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15415000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9820000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15415000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9820000
CY2023 prpo Allowance For Doubtful Accounts Revenue
AllowanceForDoubtfulAccountsRevenue
218000
CY2022 prpo Allowance For Doubtful Accounts Revenue
AllowanceForDoubtfulAccountsRevenue
408000
CY2023 us-gaap Revenues
Revenues
15197000
CY2022 us-gaap Revenues
Revenues
9412000
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
3873000
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
3390000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2572000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2354000
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1301000
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1036000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2354000
CY2023 prpo Allowance For Doubtful Accounts Revenue
AllowanceForDoubtfulAccountsRevenue
218000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
218000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2572000
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-004365-index-headers.html Edgar Link pending
0001558370-24-004365-index.html Edgar Link pending
0001558370-24-004365.txt Edgar Link pending
0001558370-24-004365-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
prpo-20231231.xsd Edgar Link pending
prpo-20231231x10k.htm Edgar Link pending
prpo-20231231xex21d1.htm Edgar Link pending
prpo-20231231xex23d1.htm Edgar Link pending
prpo-20231231xex31d1.htm Edgar Link pending
prpo-20231231xex31d2.htm Edgar Link pending
prpo-20231231xex32d1.htm Edgar Link pending
prpo-20231231xex32d2.htm Edgar Link pending
prpo-20231231xex97d1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
prpo-20231231_cal.xml Edgar Link unprocessable
prpo-20231231_def.xml Edgar Link unprocessable
prpo-20231231_lab.xml Edgar Link unprocessable
prpo-20231231_pre.xml Edgar Link unprocessable
prpo-20231231x10k_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable